Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-0295-04

POLYMEDCO ULTRA-CRP High Sensitive Assay For the DIMENSION(R) systems, Catalog No. USC300. Contents: 4 x 50...

Polymedco, Inc.,/Polymedco Cancer Diagnostic Products, LLC / initiated 2003-12-03 / Terminated / root cause: labeling and UDI

Polymedco, Inc began a recall of POLYMEDCO ULTRA-CRP High Sensitive Assay For the DIMENSION(R) systems, Catalog No. USC300. Contents: 4 x 50 Tests. For In Vitro Diagnostic (IVD) use only... on . The reason FDA records is "Firm was notified by the foreign manufacturer that certain lots of Ultra-CRP are prone to prozone (a condition of antibody antigen excess) and do not meet the labeled specifications". As of , the recall status on record is Terminated, and MDM tags the root cause as labeling and UDI.

Recall record

Recall number
Z-0295-04
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
Polymedco, Inc.,/Polymedco Cancer Diagnostic Products, LLC
Product
POLYMEDCO ULTRA-CRP High Sensitive Assay For the DIMENSION(R) systems, Catalog No. USC300. Contents: 4 x 50 Tests. For In Vitro Diagnostic (IVD) use only. COMMON/USUAL NAME: High-Sensitive C-Reactive Protein --- CLASSIFICATION NAME: C-reactive Protein, Antigen, Antiserum.
Product code
DCK C-Reactive Protein, Antigen, Antiserum, And Control
Reason for recall
Firm was notified by the foreign manufacturer that certain lots of Ultra-CRP are prone to prozone (a condition of antibody antigen excess) and do not meet the labeled specifications.
Root cause tag
labeling and UDI
FDA root cause
Other
Action
By phone on 12/3/03 and by mail on 12/5/03.
Quantity in commerce
165 Kits
Distribution
Medical facilities, physicians, diagnostic laboratories, and distributors located nationwide.
Product codes and lots
Lot numbers CP4274-0769M (EXP. 09/04) and CP4335-0812M (EXP. 11/04)